Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
Pipeline News and Updates
Picture

Update for July 27, 2021

7/26/2021

 
Regulatory Update
 
The FDA approved odevixibat (Bylvay, Albireo Pharma), on 7/20/2021, for the treatment of progressive familial intrahepatic cholestasis (PFIC) pruritus.
 
The FDA approved fexinidazole, on 7/19/2021, for the treatment of Human African trypanosomiasis in patients 6 years of age and older and weighing at least 20 kg.
 
The FDA rejected retifanlimab and requested additional data to demonstrate a clinical benefit in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the anal canal.
 
The FDA rejected sulopenem etzadroxil/probenecid, for the treatment of uncomplicated urinary tract infections (UTI) resistant to quinolones. The FDA also requested an additional trial using a different comparator antibiotic. 
 
The FDA delayed approval of Novartis’ inclisiran, in December 2020, because travel restrictions delayed the inspection of the manufacturing plant. Novartis was in the process of moving manufacturing to its own plant in Austria from an Italian plant run by contractor Corden Pharma, when it received the rejection. Novartis completed the transfer and refilled an NDA in July 2021, listing the Novartis owned site for manufacturing. A new PDUFA date was set for 1/1/2022.
 
The FDA delayed the PDUFA date for abrocitinib. A new date has not been announced.
 
The European Commission approved elivaldogene autotemcel (Skysina/Lenti-D, Bluebird Bio) to treat early cerebral adrenoleukodystrophy (CALD) in patients less than 18 years of age with an ABCD1 genetic mutation, and for whom a human leukocyte antigen matched sibling hematopoietic stem cell donor is not available. 


Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.